v3.26.1
Statements of Operations and Comprehensive Loss (FY) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 04, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:          
Research and development   $ 4,093 $ 7,737 $ 23,276 $ 40,179
General and administrative   4,787 6,085 19,875 24,988
Impairment of long-lived assets     2,637 6,145 5,233
Net gain on lease termination $ (600) (633)      
Loss from operations   (8,247) (16,459) (49,296) (70,400)
Other income (expense), net   688 1,054 3,774 5,633
Net loss   $ (7,559) $ (15,405) $ (45,522) $ (64,767)
Per share information:          
Net loss per share of common stock, basic   $ (2.36) $ (4.87) $ (14.35) $ (21.04)
Net loss per share of common stock, diluted   $ (2.36) $ (4.87) $ (14.35) $ (21.04)
Weighted average common shares outstanding, basic   3,205,866 3,163,914 3,172,870 3,078,665
Weighted average common shares outstanding, diluted   3,205,866 3,163,914 3,172,870 3,078,665
Comprehensive loss:          
Net loss   $ (7,559) $ (15,405) $ (45,522) $ (64,767)
Unrealized gain (loss) on marketable securities     (8) (8) 51
Comprehensive loss   $ (7,559) $ (15,413) $ (45,530) $ (64,716)